- Home
- MGN vs MYO Comparison
MGN vs MYO Comparison
Compare MGN & MYO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MGN
- MYO
- Stock Information
- Founded
- MGN 2020
- MYO 2004
- Country
- MGN Malaysia
- MYO United States
- Employees
- MGN N/A
- MYO N/A
- Industry
- MGN
- MYO Industrial Specialties
- Sector
- MGN
- MYO Health Care
- Exchange
- MGN Nasdaq
- MYO Nasdaq
- Market Cap
- MGN 43.0M
- MYO 40.8M
- IPO Year
- MGN 2025
- MYO 2017
- Fundamental
- Price
- MGN $1.86
- MYO $1.11
- Analyst Decision
- MGN
- MYO Strong Buy
- Analyst Count
- MGN 0
- MYO 3
- Target Price
- MGN N/A
- MYO $7.83
- AVG Volume (30 Days)
- MGN 864.1K
- MYO 2.2M
- Earning Date
- MGN 11-07-2025
- MYO 11-10-2025
- Dividend Yield
- MGN N/A
- MYO N/A
- EPS Growth
- MGN N/A
- MYO N/A
- EPS
- MGN 0.07
- MYO N/A
- Revenue
- MGN $13,484,571.00
- MYO $40,760,091.00
- Revenue This Year
- MGN N/A
- MYO $24.69
- Revenue Next Year
- MGN N/A
- MYO $20.91
- P/E Ratio
- MGN $25.23
- MYO N/A
- Revenue Growth
- MGN N/A
- MYO 93.08
- 52 Week Low
- MGN $1.60
- MYO $0.80
- 52 Week High
- MGN $8.63
- MYO $7.17
- Technical
- Relative Strength Index (RSI)
- MGN N/A
- MYO 52.00
- Support Level
- MGN N/A
- MYO $1.04
- Resistance Level
- MGN N/A
- MYO $1.16
- Average True Range (ATR)
- MGN 0.00
- MYO 0.12
- MACD
- MGN 0.00
- MYO 0.01
- Stochastic Oscillator
- MGN 0.00
- MYO 33.87
About MGN Megan Holdings Limited Ordinary Shares
Megan Holdings Ltd is principally engaged in the development, construction and maintenance of aquaculture farms and related works. Its operations are based in Malaysia. The company's operating segments include: Aquaculture and agriculture; Industrial solutions; and Investment in marketable securities. It derives maximum revenue from Aquaculture and agriculture, which involves development, construction, and maintenance of aquaculture and agriculture farms and related works.
About MYO Myomo Inc.
Myomo Inc is a wearable medical robotics company that develops, designs, and produces myoelectric orthotics for people with neuromuscular disorders. The MyoPro myoelectric upper limb orthosis product is registered with the Food and Drug Administration as a Class II medical device. The company provides the devices to patients and bills their insurance companies directly, sometimes utilizing the clinical services of orthotics and prosthetics providers for which a fee is paid. The company sells the product to orthotics and prosthetics providers around the world and the Veterans Health Administration (VA).